Akari Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
29 Dec 23 | BuyUS$1,000,001 | Raymond Prudo-Chlebosz | Individual | 473,934 | US$2.11 | |
06 Oct 23 | BuyUS$430,000 | Raymond Prudo-Chlebosz | Individual | 130,303 | US$3.30 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 419,745 | 5.3% |
Institutions | 866,563 | 10.9% |
Individual Insiders | 2,609,691 | 32.9% |
General Public | 4,027,696 | 50.8% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 56.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,307,202 | US$1.8m | 394% | no data | |||
1,165,790 | US$1.6m | 68.5% | no data | |||
553,804 | US$753.2k | 0% | no data | |||
400,383 | US$544.5k | 0% | no data | |||
164,026 | US$223.1k | -7.9% | 1.68% | |||
87,628 | US$119.2k | 0% | 0.07% | |||
76,698 | US$104.3k | 59.1% | no data | |||
23,643 | US$32.2k | 0% | no data | |||
19,355 | US$26.3k | 0% | no data | |||
19,354 | US$26.3k | 0% | 100.0% | |||
10,269 | US$14.0k | -41.2% | no data | |||
10,000 | US$13.6k | -5.53% | no data | |||
10,000 | US$13.6k | 0% | no data | |||
10,000 | US$13.6k | 0% | no data | |||
10,000 | US$13.6k | 0% | no data | |||
10,000 | US$13.6k | 0% | no data | |||
10,000 | US$13.6k | 0% | no data | |||
6,114 | US$8.3k | 0% | no data | |||
1,512 | US$2.1k | -1.88% | no data | |||
150 | US$203.7 | 0% | no data | |||
50 | US$67.9 | 0% | no data | |||
8 | US$10.8 | 0% | no data | |||
7 | US$9.7 | 0% | no data | |||
5 | US$6.5 | 0% | no data | |||
1 | US$1.1 | 0% | no data |